Capecitabine dispersible tablet and preparation method thereof

A technology of capecitabine and dispersible tablets, which is applied in the direction of non-active ingredient medical preparations, active ingredient-containing medical preparations, and pharmaceutical formulas, and can solve the problems that the stability and dissolution rate are difficult to meet the requirements of the Pharmacopoeia. Achieve good application prospects, enhance bioavailability, and simple production process

Active Publication Date: 2013-03-27
哈药集团股份有限公司 +1
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] But in the process of preparing dispersible tablets, the inventors found that the results obtained using different formulations and different process conditions vary widely, especially in terms of stability and diss

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Capecitabine dispersible tablet and preparation method thereof
  • Capecitabine dispersible tablet and preparation method thereof
  • Capecitabine dispersible tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Add 75% capecitabine to a 120-mesh sieve, microcrystalline cellulose 10% (w / w), and croscarmellose sodium 15% (w / w) into a three-dimensional motion mixer and mix thoroughly Uniformly; put the uniformly mixed material into a high-efficiency wet granulator, and set aside; add 5% polyvinylpyrrolidone K30 soft material, pass through a 20-mesh sieve, dry at 50°C, dry for 6 hours, granulate, and mix Uniform, ready to be pressed into tablets.

Embodiment 2

[0068] Add 80% capecitabine to a 120-mesh sieve, microcrystalline cellulose 7.5% (w / w), and croscarmellose sodium 7.5% (w / w) into a three-dimensional motion mixer and mix thoroughly Uniformly; put the uniformly mixed material into a high-efficiency wet granulator, and set aside; add 5% polyvinylpyrrolidone K30 soft material, pass through a 20-mesh sieve, dry at 50°C, dry for 6 hours, granulate, and mix Uniform, ready to be pressed into tablets.

Embodiment 3

[0070] Add capecitabine 75%, microcrystalline cellulose 15% (w / w), and croscarmellose sodium 7.5% (w / w) into a three-dimensional motion mixer, and mix well; Put the material into a high-efficiency wet granulator, and set it aside; add 2.5% polyvinylpyrrolidone K30 soft material, pass through a 20-mesh sieve, dry, granulate, mix evenly, and tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Meshaaaaaaaaaa
Meshaaaaaaaaaa
Login to view more

Abstract

The invention discloses a capacitabine dispersible tablet and a preparation method thereof. The formula of the dispersible tablet is as follows: the proportion of a main drug of capacitabine ranges from 70%-80%; the proportion of an adhesive of polyvinylpyrrolidone K30 ranges from 3%-7%; the proportion of a disintegrating agent of cross-linked sodium carboxymethyl cellulose ranges from 3%-7%; and the proportion of a filling agent of microcrystalline cellulose ranges from 10%-20%.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a safe and stable capecitabine dispersible tablet and a preparation method thereof. Background technique [0002] Capecitabine (English name Capecitabine) is the first oral fluoropyrimidine carbamate antineoplastic drug, and its chemical name is 5′-deoxy-5-fluoro-N[(pentyloxy)carbonyl]-cell ( pyrimidine nucleosides. Chemical Structure: [0003] [0004] Capecitabine is suitable for single-drug adjuvant therapy for colon cancer patients with Dukes' C stage, after radical resection of the primary tumor, who are suitable for fluoropyrimidine therapy alone. The disease-free survival (DFS) of its treatment is not inferior to that of 5-fluorouracil and leucovorin (5-FU / LV). Neither capecitabine alone nor in combination with other drugs can prolong overall survival (OS), but experimental data have shown that capecitabine in combination chemotherapy can improve disease-fr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/7068A61K47/38A61P35/00
Inventor 袁淑杰王丽娜苏宏健王忠李郑武崔琳马赛高晶宋紫玉
Owner 哈药集团股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap